Anna Moseley
Impact in
- Family Practice top 10%
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 5
- Oncology 11
- Cancer Treatment and Pharmacology 2
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
- Co-authors
- Dawn L. Hershman (12 shared papers)Joseph M. Unger (12 shared papers)Scott D. Ramsey (8 shared papers)Banu Symington (3 shared papers)Mariana Chávez‐MacGregor (3 shared papers)Megan Othus (21 shared papers)Harry P. Erba (18 shared papers)Mark R. Litzow (7 shared papers)
- Journals
- Blood (11 papers)Journal of Clinical Oncology (10 papers)Cancer Research (2 papers)Blood Advances (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesUnited KingdomMalaysia
In The Last Decade
Anna Moseley
31 papers receiving 691 citations
Peers
Comparison fields: 5 of 70
- Family Practice 25
- Hematology 142
- Oncology 223
- Public Health, Environmental and Occupational Health 204
- Genetics 26
Countries citing papers authored by Anna Moseley
This map shows the geographic impact of Anna Moseley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Moseley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Moseley more than expected).
Fields of papers citing papers by Anna Moseley
This network shows the impact of papers produced by Anna Moseley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Moseley. The network helps show where Anna Moseley may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Moseley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 156 | |
| 2 | 2021 | 92 | |
| 3 | 2017 | 74 | |
| 4 | SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia | 2022 | 57 |
| 5 | 2020 | 54 | |
| 6 | 2020 | 53 | |
| 7 | 2022 | 42 | |
| 8 | 2018 | 32 | |
| 9 | 1974 | 20 | |
| 10 | 2021 | 16 | |
| 11 | 2016 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2018 | 9 | |
| 16 | 2019 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2017 | 7 | |
| 19 | 2018 | 6 | |
| 20 | 2017 | 4 |
About Anna Moseley
Anna Moseley is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Molecular Biology and Genetics, having authored 36 papers that have together received 701 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Economic and Financial Impacts of Cancer (3 papers), Cancer Treatment and Pharmacology (2 papers), Retinoids in leukemia and cellular processes (2 papers), CAR-T cell therapy research (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Family Practice (25 citations), Hematology (142 citations), Oncology (223 citations), Public Health, Environmental and Occupational Health (204 citations) and Genetics (26 citations). Anna Moseley has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Dawn L. Hershman, Joseph M. Unger, Scott D. Ramsey, Banu Symington, Mariana Chávez‐MacGregor, Megan Othus, Harry P. Erba, Mark R. Litzow, Christabel K. Cheung and Raymond U. Osarogiagbon. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer Research, Blood Advances and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.